Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues
Expert Review of Clinical Pharmacology | February 18, 2023 | Volume: 16 | Issue: 3 | Pages: 177-179
10.1080/17512433.2023.2183192
| PMID 36803289